Demonstration of CD44 gene expression in cells from fine needle aspirates of breast lesions by the polymerase chain reaction

被引:0
|
作者
Bolodeoku, J
Yoshida, K
Yeomans, P
Wells, CA
Tarin, D
机构
[1] UNIV OXFORD,JOHN RADCLIFFE HOSP,NUFFIELD DEPT PATHOL & BACTERIOL,OXFORD OX3 9DU,ENGLAND
[2] ST BARTHOLOMEWS HOSP,DEPT HISTOPATHOL,LONDON,ENGLAND
关键词
CD44; fine needle aspirates; breast cancer;
D O I
暂无
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Aim - To demonstrate the feasibility of studying specific gene expression in fine needle aspirates from clinical lesions. The reverse transcription/polymerase chain reaction (RT-PCR) technique was used to demonstrate CD44 gene expression in cells from diagnostic fine needle aspirates taken from patients attending the outpatient clinic for breast diseases. Methods-Polyadenylated RNA was extracted from the cells remaining in the syringe barrel after fine needle aspirate cytological diagnosis of 41 patients with breast lesions. Analysis of CD44 gene expression was performed by RT-PCR using primers flanking the site for insertion of the variant exons. The resulting products were separated on 1.2% agarose gels, transferred to nylon membranes using Southern blotting and hybridised with specific probes for standard (constitutive) and variant exons of this gene. Results - On hybridisation with the CD44 standard exon probe, the expected amplified product of approximately 482 base pairs was visualised in 22 of 41 samples examined. Further hybridisation with the ((variant)) exon probes (exons 7 (v2), 8 (v3), 9b (v4), 12 (v7), and 15 (v10)) on 12 of these samples showed the presence of large molecular variants in all of these samples. However, the expression pattern detected with the probes for exons 7 (v2), 8 (v3) and 9b (v4) differed among the patients. Conclusions-Expression of the standard and variant regions of the CD44 gene in cells remaining in the syringe after fine needle aspiration was demonstrated using RT-PCR. The 5' variant exon probes seemed to show different patterns of expression among the patients. Further studies are currently being conducted to determine whether there is any correlation between expression of the various components of this gene and cytological diagnosis. Using this method, it would be possible to study the expression of other candidate marker genes in breast cancer using fine needle aspirates.
引用
收藏
页码:M307 / M309
页数:3
相关论文
共 50 条
  • [41] Increased CD44 Gene Expression in Lymphocytes Derived from Alzheimer Disease Patients
    Uberti, D.
    Cenini, G.
    Bonini, S. A.
    Barcikowska, M.
    Styczynska, M.
    Szybinska, A.
    Memo, M.
    NEURODEGENERATIVE DISEASES, 2010, 7 (1-3) : 143 - 147
  • [42] EVALUATION OF THE CAL ANTIBODY IN THE DETECTION OF MALIGNANT-CELLS IN FINE NEEDLE ASPIRATES FROM BREAST LUMPS
    HOLLEY, MP
    CLOUGH, DGF
    DUGUID, HLD
    CUSCHIERI, A
    CLINICAL ONCOLOGY, 1983, 9 (04): : 325 - 330
  • [43] Disorderly CD44 gene expression in human cancer cells can be modulated by growth conditions
    Sugino, T
    Yoshida, K
    Zhao, SR
    Goodison, S
    Tarin, D
    JOURNAL OF PATHOLOGY, 1998, 186 (01): : 17 - 23
  • [44] Rapid and reliable detection of CD44 variants in gastric carcinoma using a nested reverse transcription-polymerase chain reaction
    Wang, Yan
    Liu, Yuhong
    Xiao, Bai
    ONCOLOGY LETTERS, 2015, 10 (05) : 2962 - 2966
  • [45] Galectin-3 and CD44v6 positivity by RT-PCR method in fine needle aspirates of benign thyroid lesions
    Matesa, N.
    Samija, I.
    Kusic, Z.
    CYTOPATHOLOGY, 2007, 18 (02) : 112 - 116
  • [46] Use of a novel marker-calponin (CALP) for myoepithelial cells (MEC) in fine needle aspirates (FNA) of papillary breast lesions
    Mosunjac, MB
    Lewis, MM
    Lawson, DH
    Cohen, C
    LABORATORY INVESTIGATION, 1999, 79 (01) : 49A - 49A
  • [47] Expression of splice variants of CD44 in thyroid neoplasms derived from follicular cells
    Gu, J
    Daa, T
    Kashima, K
    Yokoyama, S
    Nakayama, I
    Noguchi, S
    PATHOLOGY INTERNATIONAL, 1998, 48 (03) : 184 - 190
  • [48] TOP2A and HER-2 gene amplification in fine needle aspirates from breast carcinomas
    Bofin, AM
    Ytterhus, B
    Hagmar, BM
    CYTOPATHOLOGY, 2003, 14 (06) : 314 - 319
  • [49] Monitoring phenotypical changes of breast cancer cells, sorted in accordance to their CD44 and CD24 marker expression
    Dahl, N.
    Leth-Larsen, R.
    Ditzel, H.
    EJC SUPPLEMENTS, 2007, 5 (08): : 22 - 22
  • [50] CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
    Boulbes, Delphine R.
    Chauhan, Gaurav B.
    Jin, Quanri
    Bartholomeusz, Chandra
    Esteva, Francisco J.
    BREAST CANCER RESEARCH AND TREATMENT, 2015, 151 (03) : 501 - 513